期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RNA干扰及其在帕金森病相关基因研究中的新进展

下载PDF
导出
摘要 RNA干扰技术作为一种强有力的基因调控手段,已被广泛应用于多种疾病的研究,包括神经系统疾病、肿瘤和抗病毒治疗研究等。其中,帕金森病等老年性疾病发病率逐年上升,给社会带来了巨大的经济负担,而其发病机制仍未清楚,但已经发现有许多基因与其发病有关,比如PINK1、α-synuclein和LRRK2等。本文将概述RNA干扰技术应用于帕金森病相关基因研究中的新进展,RNA干扰技术应用的新进展也将有所涉及。
作者 朱少平 鲍波
机构地区 广东医学院病理生理学教研室
出处 《西南军医》 2010年第2期296-298,共3页 Journal of Military Surgeon in Southwest China
关键词 RNA干扰 帕金森病 基因沉默
分类号 R742.5 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献22

  • 1孙怡,杨任民.实用中西医结合神经病学[M].北京:人民卫生出版社,1998.531-546.
  • 2Hamilton A J,Baulcombe D C.A species of small antisense RNA in post transcriptional gene silencing in plants[J].Science,1999,286:950-952.
  • 3Zamore PD,Tuschl T,Sharp P A,et al.RNAi:double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21to 23 nucleotide intervals[J].Cell,2000,101:25 -33.
  • 4Hammond S M,Bernstein E,Beach D,et al.An RNA-directed nuclease mediates post transcriptional gene silencing in Drosophila cells[J].Nature,2000,404:293 -296.
  • 5Sui G,Soohoo C,Affarel B,et al.A DNA-vector based RNAi technology to suppress gene expression in mammalian cells[J].Proc Natl Acad Sci USA,2002,99 (8):5515-5520.
  • 6王欢,黄敏.RNAi技术研究进展及其基因治疗应用前景[J].现代诊断与治疗,2008,19(5):291-295. 被引量：5
  • 7Dorsett Y,Tuschl T.siRNAs:Applications in functional genomics and potential as therapeutics[J].Nat Rev Drug Discov,2004,3(4):318-329.
  • 8Silvestri,L.,V.Caputo,et al.Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism[J].Hum Mol Genet,2005,14(22):3477-3492.
  • 9Park,J.,S.B.Lee,et al.Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin[J].Nature,2006,441(7097):1157-1161.
  • 10Haque,M.E.,K.J.Thomas,et al.Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP[J].Proc Natl Acad Sci USA,2008,105(5):1716-1721.

二级参考文献67

  • 1李尧华,于顺,高亚萍,柳川,左晓虹,陈彪.揭示α-突触核蛋白与帕金森病的关系:α-突触核蛋白单克隆抗体的研究[J].中国临床康复,2005,9(1):44-46. 被引量：12
  • 2Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson' s disease. Science 1997; 276 (5321 ):2045 - 7.
  • 3Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson' s disease. Nat G enet 1998; 18 (2): 106 -8.
  • 4Spillantini MC, Crowther RA, Jakes R, et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson' s disease and dementia with lewy bodies. Proc Natl Acad Sci USA 1998; 95 ( 11 ): 6469 - 73.
  • 5Yu S, Zuo X, Li Y, et al. Inhibition of tyrosine hydroxylase expression in a-synuclein-transfected dopaminergic neuronal cells. Neurosci Lett 2004; 367(1):34-9.
  • 6Perez RG, Waymire JC, Lin E, et al. A role for alpha-synuclein in the regulation of dopamine biosynthesis.J Neurosci 2002:22 (8 ): 3090 -9.
  • 7Richtand NM, Inagami T, Kuczenski R, et al. Purification and characterization of rat striatal tyrosine hydroxylase. Comparison of the activation by cyclic AMP-dependent phosphorylation and by other effectors. J Biol Chem 1985; 260(14): 8456 -73.
  • 8Lindgren N, Xu ZQ, Lindskog M, et al. Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate N MDA receptors in rat striatum. J Neurochem 2000; 74(6): 2470 - 7.
  • 9Kumer SC, Vrana KE. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 1996; 67 (2): 443 - 62.
  • 10Paisan-Ruiz C,Jain S,Evans EW,et al.Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.Neuron,2004,44 (4):595-600.

共引文献21

西南军医
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部